Search research articles
Contact Us
Filters
Showing results (551-560 of 917) with videos related to
Page
of 92
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis
Ruben C Hartkoorn, Olga B Ryabova, Laurent R Chiarelli, et al.
Antimicrobial Agents and Chemotherapy
|
April 22, 2015
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis
Anthony Vocat, Ruben C Hartkoorn, Benoit Lechartier, et al.
Infection and Immunity
|
March 25, 2004
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6
Caroline Demangel, Priscille Brodin, Paul J Cockle, et al.
Journal of Bacteriology
|
September 6, 2006
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence
Brigitte Saint-Joanis, Caroline Demangel, Mary Jackson, et al.
Infection and Immunity
|
October 1, 1992
Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis
G T Cole, K Saha, K R Seshan, et al.
Infection and Immunity
|
October 26, 1999
Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain
R Brosch, W J Philipp, E Stavropoulos, et al.
Biological Chemistry Hoppe-Seyler
|
September 1, 1992
Studies on human porin. VIII. Expression of "Porin 31HL" channels in the plasmalemma of the acute-lymphoblastic-leukemia cell line KM3 as revealed by light- and electron-microscopy
T Cole, L A Awni, E Nyakatura, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
Jérémie Piton, Anthony Vocat, Andréanne Lupien, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2010
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis
Claudia Sala, Neeraj Dhar, Ruben C Hartkoorn, et al.
Journal of the American Chemical Society
|
September 11, 2010
Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer, Monica Rengifo-Gonzalez, Marlon J Hinner, et al.
Page
of 92
Search research articles
Search
Showing results (551-560 of 917) with videos related to
Sort By:
Page
of 92
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis
Ruben C Hartkoorn, Olga B Ryabova, Laurent R Chiarelli, et al.
Antimicrobial Agents and Chemotherapy
|
April 22, 2015
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis
Anthony Vocat, Ruben C Hartkoorn, Benoit Lechartier, et al.
Infection and Immunity
|
March 25, 2004
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6
Caroline Demangel, Priscille Brodin, Paul J Cockle, et al.
Journal of Bacteriology
|
September 6, 2006
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence
Brigitte Saint-Joanis, Caroline Demangel, Mary Jackson, et al.
Infection and Immunity
|
October 1, 1992
Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis
G T Cole, K Saha, K R Seshan, et al.
Infection and Immunity
|
October 26, 1999
Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain
R Brosch, W J Philipp, E Stavropoulos, et al.
Biological Chemistry Hoppe-Seyler
|
September 1, 1992
Studies on human porin. VIII. Expression of "Porin 31HL" channels in the plasmalemma of the acute-lymphoblastic-leukemia cell line KM3 as revealed by light- and electron-microscopy
T Cole, L A Awni, E Nyakatura, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
Jérémie Piton, Anthony Vocat, Andréanne Lupien, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2010
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis
Claudia Sala, Neeraj Dhar, Ruben C Hartkoorn, et al.
Journal of the American Chemical Society
|
September 11, 2010
Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer, Monica Rengifo-Gonzalez, Marlon J Hinner, et al.
Page
of 92